Literature DB >> 11301218

Language regression in childhood.

S Shinnar1, I Rapin, S Arnold, R F Tuchman, L Shulman, K Ballaban-Gil, M Maw, R K Deuel, F R Volkmar.   

Abstract

Language regression is observed both in autistic regression and as part of acquired epileptic aphasia (Landau-Kleffner Syndrome). We prospectively identified 177 children with language regression at four major medical centers, and their clinical characteristics were recorded. Their mean age at regression was 22.8 months. The mean time-to-specialist referral was 38 months of age. Most children (88%) met criteria for autism or manifested autistic features. Males (P = 0.02) and children less than 3 years of age who regressed (P = 0.016) had a higher probability of developing autistic behaviors. Seizures were more common in children who regressed after they reached 3 years of age (P < 0.001), and children with seizures were less likely to have associated autistic regression (P < 0.001). Electroencephalogram abnormalities were reported in 37% of patients and were more common in children with seizures (P < 0.001). At last follow-up, language function was impaired in 88% of the children, although some improvement was noted in 57%. We conclude that the loss of previously acquired language at any age, even if that language only includes a few words or communicative gestures, is often associated with a more global regression in cognition and/or behavior and has serious implications for future function. Early identification and referral of these children is necessary to allow for diagnosis and intervention.

Entities:  

Mesh:

Year:  2001        PMID: 11301218     DOI: 10.1016/s0887-8994(00)00266-6

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  28 in total

Review 1.  The neurobiology of autism: new pieces of the puzzle.

Authors:  Maria T Acosta; Phillip L Pearl
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

2.  Is there a 'regressive phenotype' of Autism Spectrum Disorder associated with the measles-mumps-rubella vaccine? A CPEA Study.

Authors:  Jennifer Richler; Rhiannon Luyster; Susan Risi; Wan-Ling Hsu; Geraldine Dawson; Raphael Bernier; Michelle Dunn; Susan Hepburn; Susan L Hyman; William M McMahon; Julie Goudie-Nice; Nancy Minshew; Sally Rogers; Marian Sigman; M Anne Spence; Wendy A Goldberg; Helen Tager-Flusberg; Fred R Volkmar; Catherine Lord
Journal:  J Autism Dev Disord       Date:  2006-04

3.  Characteristics, Early Development and Outcome of Parent-Reported Regression in Autism Spectrum Disorder.

Authors:  Sofie Boterberg; Rudy Van Coster; Herbert Roeyers
Journal:  J Autism Dev Disord       Date:  2019-11

Review 4.  Autism.

Authors:  Jeremy Parr
Journal:  BMJ Clin Evid       Date:  2010-01-07

Review 5.  Epilepsy in autism spectrum disorders.

Authors:  Roberto Canitano
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-24       Impact factor: 4.785

6.  Early Identification of Autism: Early Characteristics, Onset of Symptoms, and Diagnostic Stability.

Authors:  Sara Jane Webb; Emily J H Jones
Journal:  Infants Young Child       Date:  2009 Apr-Jun

7.  Exploring the relationship between autism spectrum disorder and epilepsy using latent class cluster analysis.

Authors:  Michael L Cuccaro; Roberto F Tuchman; Kara L Hamilton; Harry H Wright; Ruth K Abramson; Jonathan L Haines; John R Gilbert; Margaret Pericak-Vance
Journal:  J Autism Dev Disord       Date:  2012-08

Review 8.  Autism: in search of susceptibility genes.

Authors:  Janine A Lamb; Jeremy R Parr; Anthony J Bailey; Anthony P Monaco
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

Review 9.  Regression in autistic spectrum disorders.

Authors:  Gerry A Stefanatos
Journal:  Neuropsychol Rev       Date:  2008-10-28       Impact factor: 7.444

Review 10.  The role of epilepsy and epileptiform EEGs in autism spectrum disorders.

Authors:  Sarah J Spence; Mark T Schneider
Journal:  Pediatr Res       Date:  2009-06       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.